TTD | Drug: D03RFK

Drug General Information
Drug ID	D03RFK
Former ID	DIB015202
Drug Name	GTP-200
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Phase 2	[548242]
Target and Pathway
Target(s)	Growth hormone secretagogue receptor type 1	Target Info	Agonist	[544045]
KEGG Pathway	cAMP signaling pathway
KEGG Pathway	Neuroactive ligand-receptor interaction
NetPath Pathway	Leptin Signaling Pathway
Reactome	Peptide ligand-binding receptors
Reactome	G alpha (q) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 548242	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023682)
Ref 544045	Orphan GPCR research. Br J Pharmacol. 2008 March; 153(Suppl 1): S339-S346.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information